Study Links Antidepressants and Antidiarrheal Drugs to Slightly Higher Mortality Risk in IBS Patients
By
Marcia Frellick
Summary
A study published in Communications Medicine found that antidepressants and certain antidiarrheal drugs (mu receptor agonists like loperamide and diphenoxylate) are linked to a slightly higher risk for death in adults with irritable bowel syndrome (IBS). The retrospective cohort study used the TriNetX Analytics US EHR database from 2005 to 2023, raising concerns about the safety of these medications in IBS treatment and calling for new considerations in long-term prescribing.
Source
Key quotes
· 2 pulledThe findings, published in Communications Medicine, raise concerns about the safety of antidepressants and mu receptor agonists in IBS treatment and call for new considerations in long-term prescribing, the authors wrote.
Researchers performed a retrospective cohort study using the TriNetX Analytics US electronic health record (EHR) database from 2005 to 2023.
You might also wanna read

Chronic opioid use linked to higher infection and mortality risks in IBD patients: nationwide cohort study
This nationwide cohort study examines the association between chronic opioid use (COU) in patients with inflammatory bowel disease (IBD) and
BBC doctor warns naproxen, ibuprofen and metformin can cause serious stomach issues if taken incorrectly
BBC Morning Live doctor Dr Kasim Ahmed warns that common medications like ibuprofen, naproxen, metformin, and lithium can cause serious stom
Analytical Review: Finasteride's Link to Depression and Suicidality
This analytical review examines the serious neuropsychiatric side effects of finasteride, a drug commonly used for hair loss treatment. The
Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients
A study analyzing over 6,800 colon cancer patients across University of California Health sites found that patients taking GLP-1 medications
Pharmaceutical LSD (MM120) Shows Promise in Treating Generalized Anxiety Disorder in UCSF Clinical Trials
Researchers at UCSF are testing MM120, a pharmaceutical form of LSD, as a treatment for generalized anxiety disorder (GAD). The treatment ha
GLP-1 drugs like Ozempic may improve mood by altering gut microbiome, study suggests
Recent research from Southeast University in China, led by Honghong Yao, suggests that GLP-1 drugs like Ozempic may improve mood in depresse

Comments
Sign in to join the conversation.
No comments yet. Be the first.